Meilleure Health International Industry Group Ltd is an investment holding company mainly engaged in the production and sale of cannabis health products. The Company operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.

Employees

Sector

Pharmaceuticals

Calendar

08-27 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
26-08-19	HK$0.2270	-4.62%	36,000
26-08-19	HK$0.2380	0.00%	50,000
26-08-18	HK$0.2380	+2.15%	42,000
26-08-17	HK$0.2330	-2.92%	156,000
26-08-14	HK$0.2400	+3.45%	594,000

Delayed Quote Hong Kong S.E.

More quotes

Income Statement and Estimates

More financial data

Delayed Hong Kong S.E. 21:20:03 2026-08-19 EDT			5-day change	1st Jan Change
0.2270 ^HKD	-4.62%		-2.16%	-14.34%

07-22	Meilleure Health International Industry Group Limited Announces Change of Registered Office Address in Hamilton	CI
07-07	Meilleure Health Forecasts Rise in H1 Profit	MT

Market Cap	965M 123M 106M 98.6M 90.46M 170M 11.77B 173M 1.16B 456M 5.9B 462M 452M 19.51B	P/E 2024	36.7x	P/E 2025	28.5x
Enterprise Value	1.33B 170M 146M 136M 125M 235M 16.25B 239M 1.61B 629M 8.15B 638M 624M 26.95B	EV / Sales 2024	28.8x	EV / Sales 2025	39.6x
Free-Float	30.93%	Yield 2024	1.38%	Yield 2025	2.08%

07-22	Meilleure Health International Industry Group Limited Announces Change of Registered Office Address in Hamilton	CI
07-07	Meilleure Health Forecasts Rise in H1 Profit	MT
07-07	Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2026	CI
06-26	Meilleure Health International Industry Group Limited Approves Final Dividend for the Financial Year Ended 31 December 2025	CI
03-27	Meilleure Health International Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-27	Meilleure Health International Industry Group Limited Recommends Payment of Final Dividend for the Year Ended December 31, 2025, Payable on August 28, 2026	CI
01-08	Meilleure Health to Acquire Chinese Property Leasing Firm for HK$137 Million	MT
01-08	Meilleure Health International Industry to buy Jiangsu Yide for RMB124.8 million	RE
01-07	Meilleure Health International Industry Group Limited signed a Equity Interest Transfer Agreement to acquire Jiangsu Yide Investment Company Limited from Zhou Chuan and Tan Wensheng for approximately CNY 120 million.	CI
01-07	Meilleure Health International Industry Group Limited commences an Equity Buyback Plan for 409,375,663 shares, representing 10% of its issued share capital, under the authorization approved on June 27, 2025.	CI
12-31	Meilleure Health International Industry Group Limited Announces Company Secretary Changes, Effective December 31, 2025	CI
12-31	Meilleure Health International Industry Group Limited Announces Changes in Nomination Committee, Effective December 31, 2025	CI
25-08-28	Meilleure Health International Industry Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2025, Payable on 31 October 2025	CI

21-04-22	Meilleure Health International Industry : GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; RE-ELECTION OF DIRECTORS; CLOSURE OF REGISTER OF MEMBERS; AND NOTICE OF ANNUAL GENERAL MEETING	PU
21-04-22	PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 24 JUNE 2021 AT 11:00 A.M. AND ANY ADJOURNMENT THEREOF	PU
20-09-15	Meilleure Health International Industry : (1) REVISION OF ANNUAL CAP OF CONTINUING CONNECTED TRANSACTIONS FOR THE YEAR ENDING 31 DECEMBER 2020; AND (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO RENEWAL OF FRAMEWORK AGREEMENT	PU
20-08-16	Meilleure Health International Industry : INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020	PU
20-03-15	Meilleure Health International Industry : PROFIT WARNING	PU

Meilleure Health International Industry Group Limited Stock

Stocks

2327

BMG5975D1048

Pharmaceuticals

Valuation: Meilleure Health International Industry Group Limited

Chart: Meilleure Health International Industry Group Limited

Latest news : Meilleure Health International Industry Group Limited

Press Releases: Meilleure Health International Industry Group Limited

Quotes and Performance

Course Extremes

Managers and Directors: Meilleure Health International Industry Group Limited

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	-4.62%
1 week	-2.16%
Current month	-6.97%
1 month	-9.20%
3 months	-21.72%
6 months	-15.93%
Current year	-14.34%

1 week	0.23	0.24
1 month	0.22	0.26
Current year	0.21	0.3
1 year	0.21	0.31
3 years	0.11	0.32
5 years	0.11	0.48
10 years	0.11	1.64

Manager	Title	Age	Since
Wen Chuan Zhou CEO	Chief Executive Officer	43	2013-08-29
Kwai Kwan Tsoi SEC	Corporate Secretary	34	2025-12-30
Mei Yi Chu SEC	Corporate Secretary	33	2025-12-30

Director	Title	Age	Since
Xu Zhou Zhou CHM	Chairman	70	2013-08-29
Wen Chuan Zhou BRD	Director/Board Member	43	2013-08-29
Chi Wai Chau BRD	Director/Board Member	64	2013-08-29

Date	Insider	Type	Main position	Quantity	% Market Cap.
7/14/26	Xu Zhou Zhou	Other	Chairman	780,000	0.0192%
7/8/26	Wen Chuan Zhou	Other	Chief Executive Officer	240,000	0.0059%
1/2/26	Xu Zhou Zhou	Other	Chairman	13,914,000	0.3399%

	2024	2025
Net sales	50.68M 6.46M 5.54M 5.18M 4.75M 8.93M 618M 9.08M 61.09M 23.92M 310M 24.27M 23.74M 1.02B	36.52M 4.66M 4M 3.73M 3.42M 6.44M 445M 6.54M 44.02M 17.24M 223M 17.49M 17.11M 738M
Net income	32.48M 4.14M 3.55M 3.32M 3.04M 5.72M 396M 5.82M 39.15M 15.33M 199M 15.55M 15.22M 657M	37.98M 4.84M 4.16M 3.88M 3.56M 6.69M 463M 6.8M 45.79M 17.93M 232M 18.19M 17.79M 768M
Net Debt	273M 34.83M 29.88M 27.9M 25.6M 48.14M 3.33B 48.93M 329M 129M 1.67B 131M 128M 5.52B	368M 46.92M 40.25M 37.58M 34.48M 64.84M 4.48B 65.91M 443M 174M 2.25B 176M 172M 7.44B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED	-4.62%	-2.16%	-10.98%	-10.98%	123M
ELI LILLY AND COMPANY	+4.46%	+4.92%	+82.07%	+134.31%	1,093B
JOHNSON & JOHNSON	+0.85%	+4.81%	+53.77%	+58.51%	653B
ABBVIE INC.	+2.72%	+6.92%	+28.99%	+77.15%	458B
ROCHE HOLDING AG	+1.80%	+0.52%	+41.20%	+44.05%	355B
NOVARTIS AG	+1.24%	+2.35%	+25.99%	+42.21%	294B
ASTRAZENECA PLC	+2.07%	+2.97%	+2.27%	+13.06%	248B
AMGEN INC.	+4.02%	+6.29%	+49.67%	+68.96%	230B
NOVO NORDISK A/S	+1.05%	-0.02%	-13.96%	-52.13%	203B
GILEAD SCIENCES, INC.	+2.90%	+8.63%	+25.11%	+94.52%	178B
Average	+1.27%	+2.65%	+28.41%	+46.96%	371.06B
Weighted average by Cap.	+1.53%	+3.65%	+46.87%	+73.74%